Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent
DOI 10.1016/S0889-8561(03)00098-5
Belshe RB, Mendelman PM: Safety and efficacy of live attenuated, coldadapted, influenza vaccine-trivalent. Immunol Allergy Clin North Am 2003; 23:745-767. (Pubitemid 38030167)
Sublingual vaccination with influenza virus protects mice against lethal viral infection
DOI 10.1073/pnas.0708684105
Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, Czerkinsky C, Kweon MN: Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci USA 2008;105:1644-1649. (Pubitemid 351346568)
Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses
DOI 10.1111/j.1399-302X.2007.00400.x
Koizumi Y, Kurita-Ochiai T, Yamamoto M: Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses. Oral Microbiol Immunol 2008;23:131-138. (Pubitemid 351248608)
Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice
DOI 10.1016/j.vaccine.2006.10.014, PII S0264410X06011339
Tanaka N, Fukuyama S, Fukuiwa T, et al: Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice. Vaccine 2007;25:2680-2687. (Pubitemid 46400925)
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
DOI 10.1056/NEJMoa030595
Mutsch M, Zhou W, Rhodes P, et al: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004;350:896-903. (Pubitemid 38252537)